Year: 2021
Type: review
Abstract: CONTEXT: The International Association for the Study of Pain (IASP) defines chronic pain as pain that persists or recurs for longer than 3 months. Chronic pain has a significant global disease burden with profound effects on health, quality of life, and socioeconomic costs. EVIDENCE ACQUISITION: Narrative review. RESULTS: There are several treatment options, including pharmacological therapy, physical rehabilitation, psychological therapies, and surgical interventions, for chronic pain management. Magnesium has been FDA-approved for several indications including hypomagnesemia, arrhythmia, prevention of seizures in eclampsia/preeclampsia, and constipation. Magnesium has been used for numerous off-label uses, notably for acute and chronic pain management. The mechanism of magnesium in pain management is primarily through its action as a voltage-gated antagonist of NMDA receptors, which are involved in pain transduction. CONCLUSIONS: This narrative review will focus on the current evidence and data surrounding the utilization of magnesium as a treatment option for chronic pain.
Source: Anesthesiology and Pain Medicine
DOI: 10.5812/aapm.112348
Institutions: SouthCoast Health, Louisiana State University Health Sciences Center Shreveport, Georgetown University, University of Pittsburgh Medical Center, Iran University of Medical Sciences, Fondazione Paolo Procacci, Pennsylvania State University, Penn State Milton S. Hershey Medical Center, Creighton University, University of Arizona College of Medicine- Phoenix
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W3126503526
